Rooibos Extract Composition for Linear Polyphenol Release

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The rapid elimination and poor absorption of phenolic compounds in Rooibos (Aspalathus linearis) after oral consumption lead to short-lived health benefits, necessitating frequent consumption to maintain effectiveness, and existing formulations fail to provide a sustained release profile.

Innovation Solution

A multi-unit pharmaceutical composition with immediate and sustained release components, utilizing specific excipients like sodium bicarbonate, vinylpyrrolidone-vinyl acetate, and rate-controlling polymers, to achieve a substantially linear polyphenol release over 6-10 hours, ensuring at least 80% release within this period.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Duration of action of moving object

If Rooibos extract is consumed orally, then polyphenols are delivered to the body, but rapid elimination and poor absorption occur resulting in short-lived health benefits

Engineering Contradiction:
ImproveDuration of health benefitsVSAvoidAbsorption efficiency
Core Design Contradiction:
Duration of action of moving objectVSReliability

Solution Approach 1:

The formulation is divided into multiple granules (2-10 granules per capsule), where each granule contains a sustained release matrix. This segmentation allows for controlled, prolonged release of polyphenols over time, extending the duration of action from hours to potentially 12-24 hours while improving overall absorption efficiency through the cumulative effect of multiple release sites in the gastrointestinal tract.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent changes the physical and chemical parameters of the polyphenol delivery system by using specific excipients (hydrophilic polymers like HPMC, HPC, or sodium carboxymethyl cellulose) with controlled viscosity and molecular weight. These parameter changes create a matrix that controls the release rate of polyphenols, transforming the rapid elimination pattern into a sustained release pattern that maintains therapeutic levels for extended periods.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If multiple cups of Rooibos tea are consumed at regular intervals, then health benefits are maintained, but convenience and ease of operation deteriorate

Engineering Contradiction:
ImproveConsistency of health benefitsVSAvoidConvenience of consumption
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The patent combines multiple doses of polyphenols into a single capsule containing 2-10 sustained release granules. This merging allows the consumer to take one capsule instead of multiple cups of tea throughout the day, maintaining consistent health benefits while dramatically improving convenience. The granules release polyphenols sequentially over time, providing the equivalent of multiple doses in a single administration.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The polyphenols are pre-loaded into sustained release granules that are designed to release the active ingredients over an extended period. This preliminary action of encapsulating and controlling the release mechanism beforehand allows the body to receive a sustained supply of polyphenols without requiring repeated consumer actions, thus maintaining reliability while improving ease of operation.

Inventive Principle:
Principle #10Preliminary action

3Duration of action of moving object

If a sustained release formulation is developed, then duration of action is improved, but device complexity increases

Engineering Contradiction:
ImproveRelease duration of polyphenolsVSAvoidFormulation complexity
Core Design Contradiction:
Duration of action of moving objectVSDevice complexity

Solution Approach 1:

The patent achieves sustained release by carefully selecting and optimizing parameters of commercial excipients (viscosity, molecular weight, concentration ratios) rather than developing entirely new complex delivery systems. For example, using HPMC with specific viscosity ranges (6-10 cP at 2% w/v) or HPC with controlled molecular weights (10,000-100,000 Daltons) allows for predictable sustained release profiles while keeping the formulation relatively simple and manufacturable.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent uses homogeneous matrices composed of single or combinations of well-characterized hydrophilic polymers (HPMC, HPC, or sodium carboxymethyl cellulose) rather than complex multi-layer or multi-component systems. This homogeneity simplifies manufacturing while achieving sustained release through the inherent gel-forming and water-soluble properties of these polymers, creating a uniform matrix that releases polyphenols consistently over time.

Inventive Principle:
Principle #33Homogeneity

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The composition provides a sustained release of polyphenols, maintaining health benefits for an extended period, allowing for a single dose to be effective without frequent consumption.

Implementation Method 1

rate-controlling polymer excipients... provide sustained release of the polyphenols

Methodology Applied
Scientific EffectDiffusion: Diffusion

Implementation Method 2

rate-controlling polymer excipients... provide sustained release of the polyphenols over a predetermined and extended period of time

Methodology Applied
Scientific EffectPolymer erosion:

Data Source

PatentUS12558391B2Sustained release formulation containing <i>Aspalathus linearis </i>extract
Publication Date: 2026.02.24 CAPE PENINSULA UNIV OF TECH
  • US12558391B2 patent drawing
  • US12558391B2 patent drawing
  • US12558391B2 patent drawing

AI summary

A multi-unit pharmaceutical composition comprising an immediate release component comprising a polyphenol-containing Aspalathus linearis extract and one or more pharmaceutically acceptable excipients, and a sustained release component comprising a polyphenol-containing Aspalathus linearis extract and one or more pharmaceutically acceptable excipients, wherein the composition provides a substantially linear polyphenol release profile over a predetermined period, for example about 8 hours.